Form 4 for INM InMed Pharmaceuticals Inc.
Accepted 2022-04-13 00:00:00 ET · period of report 2022-04-13 · accession 0001213900-22-019688 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-04-13 | 2022-04-13 | INM | ADAMS ERIC A | Pres, CEO, Dir | P - Purchase | $0.85 | +8,560 | 44.8K | +24% | +$7,276 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-13 | P | A | 8,560 | $0.85 | 44,843 | D | — | — |